Metrics for Health and Wellness
November 2011. From the perspective of systems biology DNA sequencing is much more than a commodity service for research purposes bringing down cost of human genetic diagnostics. The goal is health, and up to now the approach has been looking at disease first, for example when targeting organ-specific disease biomarkers. What is the role of microfluidics performing wellness assays? What means “normal health state”? How to cope with noise in biological systems in a high throughput approach? In the interview with B2Bioworld Leroy Hood, President of the Seattle Institute for Systems Biology (WA, US) shares his experience with technologies and offers insights into tasks ahead.Reading time: 9 min
Read Now: |
Other articles recommended
B2Bioworld offers you background information
Regulatory Challenges of Big Data Operations – Algorithms, Healthcare, or Autonomous Driving
Systems Biology Applied
Rudi Balling, Director Luxembourg Centre for Systems Biomedicine,on system theory and pitfalls of loose concepts in using technologies
Customs Sequencing Markets
Worldwide evolution of the market and upcoming business opportunities